Kathleen Y. Riley
For most consultant pharmacists, changes brought by managed care are inevitable; for some, managed care is already here. Here are a few tools to help you anticipate the challenges of the changing health care marketplace.
Quality Indicators: Clinical Management
L. Michael Posey
Of all the federal indicators used in long-term care, the number
of medications residents receive on a scheduled basis provides
the most vivid endorsement of the value of consultant pharmacy
services.
Isoforms of Hepatic Microsomal Enzymes: Effects on Drug Metabolism in the Elderly
L. Michael Posey
Research during the past decade is beginning to shed new light
on the effects of aging on drug metabolism in the human liver,
and on age-related changes that have been identified with isoforms
of hepatic enzymes.
Certification: What's Ahead?
Kathleen Y. Riley
Can certification help pharmacists better meet the needs of their
patients? Although the issue raises more questions than answers,
discussions about pharmacist certification may be leading to some
bona fide certification initiatives.
Profile: Ralph Kalies
David K. Buerger
Ralph Kalies has a vision: computerized systems to amplify pharmacists'
clinical capabilities and better target disease management. And
as Kalies has pursued that vision in his own practice, he's refined
another goal: moving consultant pharmacy from a commodity paradigm
to a true outcomes paradigm.
1995-96 ASCP Policy Decisions
The full texts of 1995-96 policy decisions made by ASCP's Board
of Directors are contained in this issue of TCP.
October 1996/Volume 11, Number 10 |
 |
Pharmaceutical Care for Patients with Dementia:
Results from a Year-Long Campaign in Swedish Pharmacies
Stefan Gustafsson, Rita Holtin, Helena Löfberg, Sunne Pettersson,
Åsa Rydberg, Lena Sahlstedt, J. Lars G. Nilsson
This article examines the results of a national campaign in Swedish
pharmacies to increase understanding of dementia and improve
drug therapy for patients with dementia.
Clinical Review
Sedative and Cardiovascular Profile of Newer Antihistamines
Richard T. Scheife, Wendy R. Cramer
This article reviews clinical information about new antihistamines,
with an emphasis on adverse effects and drug-drug interactions.
| D E P A R T M E N T S |
|
Bylines Brian A. Kahan
Forum
ASCP Reports
Consultants Forum
Hearthbeat |
Pathways The Shocking Experience of Depression
Subacute Care Forum
Close to Home
Helpful Ideas
Late Additions |